Drug Search Results
More Filters [+]

Maraciclatide

Alternative Names: maraciclatide
Latest Update: 2024-09-10
Latest Update Note: News Article

Product Description

Mechanisms of Action: Radioactive Agent

Novel Mechanism: No

Modality: Peptide/Protein

Route of Administration: Injection

FDA Designation: Fast Track - Endometriosis *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: GE Healthcare
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Maraciclatide

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Heart Failure

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NCT05623332

N/A

Unknown status

Endometriosis

2023-12-01

GE-078-101

P2

Terminated

Heart Failure

2012-03-01

Recent News Events